As on Thursday, Adma Biologics Inc (NASDAQ: ADMA) started slowly as it slid -3.99% to $18.07, before settling in for the price of $18.82 at the close. Taking a more long-term approach, ADMA posted a 52-week range of $13.50-$25.67.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 19.98%. This publicly-traded company’s shares outstanding now amounts to $238.33 million, simultaneously with a float of $229.92 million. The organization now has a market capitalization sitting at $4.30 billion. At the time of writing, stock’s 50-day Moving Average stood at $17.79, while the 200-day Moving Average is $18.16.
Adma Biologics Inc (ADMA) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Adma Biologics Inc’s current insider ownership accounts for 3.40%, in contrast to 92.81% institutional ownership. According to the most recent insider trade that took place on Dec 15 ’25, this organization’s President and CEO sold 21,000 shares at the rate of 19.79, making the entire transaction reach 415,590 in total value, affecting insider ownership by 2,007,850. Preceding that transaction, on Nov 19 ’25, Company’s President and CEO sold 21,000 for 16.00, making the whole transaction’s value amount to 336,000. This particular insider is now the holder of 2,013,850 in total.
Adma Biologics Inc (NASDAQ: ADMA) Trading Performance Indicators
Let’s observe the current performance indicators for Adma Biologics Inc (ADMA). It’s Quick Ratio in the last reported quarter now stands at 3.65. Alongside those numbers, its PE Ratio stands at $21.22, and its Beta score is 0.48. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 8.80. Similarly, its price to free cash flow for trailing twelve months is now 105.59.
In the same vein, ADMA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.85, a figure that is expected to reach 0.18 in the next quarter, and analysts are predicting that it will be 0.88 at the market close of one year from today.
Technical Analysis of Adma Biologics Inc (ADMA)
Through scrutinizing the latest numbers posted by the [Adma Biologics Inc, ADMA], it can be observed that its last 5-days Average volume of 2.13 million was better the volume of 2.13 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 42.78% While, its Average True Range was 39.97.
Raw Stochastic average of Adma Biologics Inc (ADMA) in the period of the previous 100 days is set at 64.35%, which indicates a major rise in contrast to 24.90% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.60 that was lower than 0.64 volatility it exhibited in the past 100-days period.
